Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. OSIS
9. REAX
10. RMAX

Go back to Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing
ORAGENICS (NYSE: OGEN) Delayed: 0.53 -0.01 (1.85%)
Previous Close $0.54    52 Week High $2.12 
Open $0.53    52 Week Low $0.33 
Day High $0.54    P/E N/A 
Day Low $0.52    EPS $-0.45 
Volume 56,506